Tag: Besremi

FDA, Regulations

FDA approves Besremi to treat rare blood disease

November 16, 2021

Via: European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved Besremi (ropeginterferon alfa-2b-njft) injection to treat adults with polycythemia vera, a blood disease that causes the overproduction of red blood cells. Besremi is the first FDA-approved medication for polycythemia vera that […]